Noxopharm Ltd is an Australian clinical-stage drug development company focused on discovering and developing novel treatments for cancer and inflammation, as well as improving mRNA vaccines, based on two preclinical platforms... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SIVR | 30.62 | 0.87 | +2.92% |
| abrdn Physical Silver Shares ETF | |||
| DFE | 59.60 | 1.51 | +2.60% |
| WisdomTree Europe SmallCap Dividend ETF | |||
| JUST | 75.63 | 1.28 | +1.73% |
| Goldman Sachs JUST US Large Cap Eq ETF | |||
| AAA | 24.58 | -0.01 | -0.06% |
| Alternative AccessFirstPriorityCLO BdETF | |||
| QTR | 28.30 | -0.30 | -1.06% |
| Global X NASDAQ 100® Tail Risk ETF | |||
A.I.dvisor indicates that over the last year, NOXOF has been loosely correlated with NWPHF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NOXOF jumps, then NWPHF could also see price increases.
| Ticker / NAME | Correlation To NOXOF | 1D Price Change % | ||
|---|---|---|---|---|
| NOXOF | 100% | N/A | ||
| NWPHF - NOXOF | 54% Loosely correlated | N/A | ||
| NTRB - NOXOF | 29% Poorly correlated | N/A | ||
| BCRX - NOXOF | 26% Poorly correlated | +6.40% | ||
| IKT - NOXOF | 23% Poorly correlated | +11.29% | ||
| EYEN - NOXOF | 21% Poorly correlated | -1.57% | ||
More | ||||